
RIGOLIO ROBERTA
- U28, Piano: 3, Stanza: 3020
Pubblicazioni
Giambra, M., Di Cristofori, A., Raimondo, F., Rigolio, R., Conconi, D., Chiarello, G., et al. (2024). Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(5) [10.3390/ijms25052743]. Dettaglio
Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., Miloso, M. (2023). Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24021721]. Dettaglio
Fumagalli, G., Monza, L., Cavaletti, G., Rigolio, R., Meregalli, C. (2021). Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy. FRONTIERS IN IMMUNOLOGY, 11 [10.3389/fimmu.2020.626687]. Dettaglio
Malacrida, A., Rigolio, R., Celio, L., Damian, S., Cavaletti, G., Mazzaferro, V., et al. (2021). In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(15) [10.3390/ijms22158230]. Dettaglio
Malacrida, A., Cavalloro, V., Martino, E., Costa, G., Ambrosio, F., Alcaro, S., et al. (2021). Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2. MOLECULES, 26(21), 1-15 [10.3390/molecules26216596]. Dettaglio
Progetti di ricerca
Premi e responsabilità scientifiche
Premi
- Fondazione Italiana Sclerosi Multipla (FISM) progetto pilota, FISM, ente privato, 2012
- Fondazione Italiana Sclerosi Multipla (FISM) progetto pilota, FISM, ente privato, 2009